Insulet (Germany) Top Insiders
| GOV Stock | EUR 237.90 6.70 2.74% |
Insulet employs about 2.6 K people. The company is managed by 10 executives with a total tenure of roughly 6067 years, averaging almost 606.0 years of service per executive, having 260.0 employees per reported executive. Examination of Insulet's management performance can provide insight into the company performance.
| John Kapples Insider Sr Counsel |
| Wayde McMillan Insider Ex Treasurer |
Insulet |
Insulet Management Team Effectiveness
The company has return on total asset (ROA) of 0.0183 % which means that it generated a profit of $0.0183 on every $100 spent on assets. This is way below average. Insulet's management efficiency ratios could be used to measure how well Insulet manages its routine affairs as well as how well it operates its assets and liabilities.Insulet has a total of 69.54 Million outstanding shares. The majority of Insulet outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Insulet to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Insulet. Please pay attention to any change in the institutional holdings of Insulet as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Insulet in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Insulet, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Insulet Workforce Comparison
Insulet is rated below average in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 444,210. Insulet maintains roughly 2,600 in number of employees contributing less than 1% to all equities under Medical Devices industry.
Insulet Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Insulet Price Series Summation is a cross summation of Insulet price series and its benchmark/peer.
Insulet Notable Stakeholders
An Insulet stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Insulet often face trade-offs trying to please all of them. Insulet's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Insulet's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John Kapples | Sr Counsel | Profile | |
| Wayde McMillan | Ex Treasurer | Profile | |
| Angela Wiczek | Sr Communications | Profile | |
| Charles Alpuche | Ex COO | Profile | |
| Lauren Budden | Chief VP | Profile | |
| James Hollingshead | CEO Pres | Profile | |
| Michael Spears | VP Compliance | Profile | |
| Bret Christensen | Ex Officer | Profile | |
| Deborah CPA | VP Relations | Profile | |
| Shacey Petrovic | Director Advisor | Profile |
About Insulet Management Performance
The success or failure of an entity such as Insulet often depends on how effective the management is. Insulet management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Insulet management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Insulet management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts. INSULET CORP operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1169 people.
Insulet Workforce Analysis
Traditionally, organizations such as Insulet use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Insulet within its industry.Insulet Manpower Efficiency
Return on Insulet Manpower
| Revenue Per Employee | 502K | |
| Revenue Per Executive | 130.5M | |
| Net Income Per Employee | 1.8K | |
| Net Income Per Executive | 460K |
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |